Intended for healthcare professionals


Coordinated neonatal screening programme for haemoglobin disorders is needed

BMJ 1998; 316 doi: (Published 21 March 1998) Cite this as: BMJ 1998;316:937
  1. Allison Streetly, Consultant,
  2. Krista Maxwell, Research associate,
  3. Beverly Campbell, Director
  1. United Medical and Dental Schools, St Thomas's Hospital, London SE1 7EH
  2. Sickle Cell Society, London NW10 4UA

    EDITOR—Modell et al's audit of prenatal diagnosis for haemoglobin disorders shows the lack of a public health approach to the issue in the United Kingdom.1

    Firstly, numbers of affected births for sickle cell disease in the United Kingdom are not reported and, in fact, are not known. This reflects the lack of a coordinated neonatal screening programme (despite good evidence of the effectiveness of neonatal screening in reducing mortality) and of adequate data …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription